PlainRecalls
FDA Drug Moderate Class II Terminated

Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA, NDC 6191985330

Reported: March 24, 2021 Initiated: March 2, 2021 #D-0300-2021

Product Description

Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA, NDC 6191985330

Reason for Recall

cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.

Details

Recalling Firm
Direct Rx
Units Affected
17 bottles
Distribution
GA
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA, NDC 6191985330. Recalled by Direct Rx. Units affected: 17 bottles.
Why was this product recalled?
cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 24, 2021. Severity: Moderate. Recall number: D-0300-2021.